Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05015387
Other study ID # Proanthocyanidins
Secondary ID
Status Completed
Phase Phase 2
First received
Last updated
Start date January 9, 2019
Est. completion date May 9, 2019

Study information

Verified date June 2022
Source Lithuanian University of Health Sciences
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the study is to evaluate the efficacy of proanthocyanidins as an adjunctive periodontal therapy in patients with periodontitis. Recently proanthocyanidins were proposed as a viable adjunct to periodontal treatment. Preclinical studies have shown high antibacterial and anti-inflammatory capacities of proanthocyanidins, that could reduce periodontal inflammation and promote periodontal tissues regeneration. In addition, proanthocyanidins demonstrate a specific antibacterial characteristic to attack periodonto-pathogenic bacteria (Porphyromonas gingivalis) but save the oral commensal bacteria (Streptococcus salivarius). Patients with periodontitis (stage III-IV) were included in this study. Patients with periodontitis received two different treatment modalities: minimally invasive non-surgical therapy only (MINST group) or minimally invasive non-surgical therapy and subgingival application of collagen hydrogels with proanthocyanidins (MINST+PACNs group). Clinical periodontal parameters (PPD, CAL, BOP, PI) were evaluated before treatment and after 8 weeks. Concentrations of immunological markers MMP-3 and TIMP-1 in saliva were investigated.


Description:

Ethical permission was issued by the Regional Biomedical Research Ethics Committee (No. BE-2-38). All included patients must have signed an informed consent form, were willing and able to show up for follow-up appointments and agreed to coded data collection. Patients were given enough time to analyze protocol of the study and were free to exit the study at any time without a specific reason. The study was performed according to CONSORT guidelines for randomized controlled clinical trials. Patients with periodontitis (stage III-IV) were included in the study. The inclusion criteria in treatment groups were systemically healthy patients with stage III and IV periodontitis with slow or moderate rate of progression (A/B) (radiographic bone loss extending to middle or apical third of the root, tooth loss due to periodontitis, maximum probing depth≥6mm, horizontal and vertical (≥3mm) bone loss). All patients were allocated by the Examiner 1 to two groups: the first group received minimally invasive non-surgical therapy only (MINST group), the second group- minimally invasive non-surgical therapy and subgingival application of collagen hydrogels with PACNs (MINST+PACNs group). The same Examiner 1 performed the coding and randomization of the participants in the treatment groups with a computer-generated randomization table. Clinical trial protocol included several appointments. At the baseline all patients received periodontal examination by periodontist (Examiner 2), the collection of saliva samples was performed. Both groups received full-mouth minimally invasive non-surgical therapy procedure by single periodontist (Examiner 2). During the MINST procedure the periodontist (Examiner 2) was not informed about the patient 's assignment to the group (MINST or MINST+PACNs). After the procedure patient 's allocation to the group was revealed to periodontist by Examiner 1 and accordingly the patient received adjunctive treatment (in MINST+PACNs group received collagen hydrogel chips with proanthocyanidins) or ended the procedure without adjunctive therapy (MINST group). Postoperative care instructions were given (no flossing or use of chemical control materials). After the procedure patients returned for the next appointment (8 weeks after baseline). Periodontal reevaluation of encoded patients was performed by a single periodontist (Examiner 2). Saliva sample were collected in the same manner as mentioned before. The relationship of clinical periodontal parameters and MMP-3 and TIMP-1 levels were analyzed to assess the efficacy of proanthocyanidins in periodontal therapy. The statistical analysis was performed with IBM SPSS 28 (Armonk, NY: IBM Corp.) statistic software package. Shapiro-Wilk test was performed to assess if clinical periodontal measures (per-patient PPD, CAL, BOP and PI) and biochemical measures (MMP-3 and TIMP-1 concentrations in saliva) followed a normal distribution. Accordingly, if the data followed a normal distribution, paired-samples t-test was done to obtain before and after treatment comparisons within the groups. If the assumption of normality was violated, related samples Wilcoxon signed ranks test was done to obtain before and after treatment comparisons within the groups. The between group comparisons of measures were determined by either independent samples t-test in case the specific measure followed a normal distribution or Mann-Whitney test in case the specific measure followed a non-normal distribution. The statistical significance level was considered at the 0.05 level.


Recruitment information / eligibility

Status Completed
Enrollment 46
Est. completion date May 9, 2019
Est. primary completion date April 9, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years and older
Eligibility Inclusion criteria: - patients with stage III and IV periodontitis with slow or moderate rate of progression (A/B) (radiographic bone loss extending to middle or apical third of the root, tooth loss due to periodontitis, maximum probing depth=6mm, horizontal and vertical (=3mm) bone loss); - systemically healthy individuals; - have= 20 remaining teeth; - =30 years patients. Exclusion criteria: - patients with stage I and II periodontitis (radiographic bone loss in coronal third, no tooth loss due to periodontitis, maximum probing depth =5mm, mostly horizontal bone loss); - patients with systemic diseases; - had antibiotic therapy during the last 3 months; - had periodontal treatment during last 6 months; - were pregnant or lactating women; - claimed to be allergic to the adjunct (proanthocyanidins).

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Minimally invasive non-surgical therapy
Under local anesthesia subgingival instrumentation with ultrasonic and hand instruments and magnification (4.5x) was performed.
Combination Product:
Subgingival application of collagen hydrogels with proanthocyanidins
Patients received collagen hydrogel chips with proanthocyanidins from Pelargonium sidoides root extract, placed subgingivally in periodontal pockets with PPD=4mm after minimally invasive non-surgical therapy.
Diagnostic Test:
Collection of saliva samples
For MMP-3/TIMP-1 detection, the collection of saliva samples was performed using Salivette (SARSTEDT AG and Co, Germany) saliva sample collection kit. Saliva samples were collected at the baseline for all patients and 8 weeks after treatment. Samples were centrifuged at 3500 rpm (2 min), aliquoted and protease inhibitors cocktail (1 mg/ml) was added to each sample. All samples were stored at -80oC. MMP-3, TIMP-1 concentration in saliva samples was examined using commercial ELISA kits (Elabscience, USA) and Multiskan Microplate Photometer (Thermo Fisher Scientific) at 450 nm wavelength. Saliva MMP-3/TIMP-1 samples were collected before treatment and 8 weeks after treatment.

Locations

Country Name City State
Lithuania Lithuanian University of Health Sciences Kaunas

Sponsors (1)

Lead Sponsor Collaborator
Lithuanian University of Health Sciences

Country where clinical trial is conducted

Lithuania, 

References & Publications (4)

Jekabsone A, Sile I, Cochis A, Makrecka-Kuka M, Laucaityte G, Makarova E, Rimondini L, Bernotiene R, Raudone L, Vedlugaite E, Baniene R, Smalinskiene A, Savickiene N, Dambrova M. Investigation of Antibacterial and Antiinflammatory Activities of Proanthocyanidins from Pelargonium sidoides DC Root Extract. Nutrients. 2019 Nov 19;11(11). pii: E2829. doi: 10.3390/nu11112829. — View Citation

Savickiene N, Jekabsone A, Raudone L, Abdelgeliel AS, Cochis A, Rimondini L, Makarova E, Grinberga S, Pugovics O, Dambrova M, Pacauskiene IM, Baseviciene N, Viškelis P. Efficacy of Proanthocyanidins from Pelargonium sidoides Root Extract in Reducing P. gingivalis Viability While Preserving Oral Commensal S. salivarius. Materials (Basel). 2018 Aug 22;11(9). pii: E1499. doi: 10.3390/ma11091499. — View Citation

Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010 Jun 1;152(11):726-32. doi: 10.7326/0003-4819-152-11-201006010-00232. Epub 2010 Mar 24. — View Citation

Tonetti MS, Greenwell H, Kornman KS. Staging and grading of periodontitis: Framework and proposal of a new classification and case definition. J Periodontol. 2018 Jun;89 Suppl 1:S159-S172. doi: 10.1002/JPER.18-0006. Review. Erratum in: J Periodontol. 2018 Dec;89(12):1475. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Mean PPD change from baseline in moderate sites at 8 weeks Pocket probing depth is measured with periodontal probe. Pocket probing depth from gingival margin to the bottom of periodontal pocket. Before treatment and 8 weeks after baseline
Secondary Mean PPD change from baseline in deep sites at 8 week Pocket probing depth is measured with periodontal probe. Pocket probing depth from gingival margin to the bottom of periodontal pocket. Before treatment and 8 weeks after baseline
Secondary Mean CAL changes from baseline at 8 week Clinical attachment level is measured with periodontal probe. Before treatment and 8 weeks after baseline
Secondary Mean PI changes from baseline at 8 week Presence or absence of plaque is measured. Before treatment and 8 weeks after baseline
Secondary Mean BOP change from baseline in deep sites at 8 week Presence or absence of bleeding during periodontal probing. Before treatment and 8 weeks after baseline
Secondary Mean MMP-3, TIMP-1 changes from baseline at 8 week Biomarkers MMP-3 (matrix metalloproteinase-3) and TIMP-1 (endogenous tissue inhibitors of metalloproteinases-1) concentration in salivary samples. Before treatment and 8 weeks after baseline
See also
  Status Clinical Trial Phase
Recruiting NCT05065034 - Effects of Antibiotic Therapy on the Short and Long-term Results of Periodontitis Treatments
Completed NCT05456555 - The Flapless Approach in Periodontal Regeneration N/A
Completed NCT03851757 - Cleansing Efficacy of Waist-shaped Interdental Brushes. N/A
Completed NCT04240015 - Association of Periodontitis With Oral Health Related Quality of Life
Completed NCT05724251 - Effect of Iodine Deficiency on Periodontitis
Completed NCT05730153 - Advanced Platelet-rich Fibrin Combined With Open Debridement in Management of Suprabony Periodontal Defects Phase 4
Recruiting NCT06426550 - Clinical and Microbiological Evaluation of Laser Therapy in the Treatment of Periodontal Disease in Stages III and IV N/A
Not yet recruiting NCT06351722 - Non-surgical Periodontal Treatment in Smokers on SIRT-1, NLRP3 Inflammasome and LncRNAs
Recruiting NCT04149834 - Clinical and Radiographic Evaluation of NIPSA Versus M-MIST in Treatment of Intra-osseous Defects N/A
Completed NCT05466253 - Early Versus Delayed Orthodontic Treatment After Periodontal Surgery on Periodontal Health in Periodontally Compromised Patients N/A
Completed NCT04076098 - Locally Delivered Minocycline in Advanced Periodontitis Phase 4
Withdrawn NCT05646459 - Effect of Local Cannabidiol on Clinical and Inflammatory Outcomes in Periodontal Maintenance Patients. Phase 1
Not yet recruiting NCT06469294 - Evaluation of Chlorhexidine Gel Associated With Photodynamic Therapy in the Treatment in Diabetic Participants N/A
Active, not recruiting NCT03297749 - Genetic Variants and Oxidative Stress as Links Between Periodontitis and Metabolic Syndrome N/A
Completed NCT06064799 - GCF miRNA-223 , -214 Levels in Smokers and Nonsmokers Periodontitis Patients
Completed NCT03453476 - Effect of Photodynamic Therapy on Gingival Crevicular Cytokines in Periodontitis Patients N/A
Completed NCT04264624 - Efficacy of Sub-gingival Air-polishing With Erythritol in the Treatment of Periodontitis N/A
Completed NCT03178838 - Clinical Study of the Presence of Trichomonas Tenax and Entamoeba Gingivalis in Patients With Periodontitis N/A
Recruiting NCT03432975 - Evaluation of Multiple Subgingival Irrigations. N/A
Completed NCT05293301 - Utilization of a Periodontal Endoscope in Nonsurgical Periodontal Therapy N/A